{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:00:08Z","timestamp":1761541208521},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.radonc.2014.10.007","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T22:24:40Z","timestamp":1417040680000},"page":"410-413","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Dosimetric analysis of urethral strictures following HDR 192Ir brachytherapy as monotherapy for intermediate- and high-risk prostate cancer"],"prefix":"10.1016","volume":"113","author":[{"given":"Patricia","family":"D\u00edez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod","family":"Mullassery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pittaya","family":"Dankulchai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Ostler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Alonzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerry","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2014.10.007_b0005","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2004.08.014","article-title":"High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California Endocurietherapy\u2019s 10-year results","volume":"61","author":"Demanes","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.10.007_b0010","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ijrobp.2003.08.003","article-title":"Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer","volume":"58","author":"Galalae","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.10.007_b0015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijrobp.2009.10.035","article-title":"Dose escalation improves cancer- related events at 10years for intermediate and high risk prostate cancer patients treated with hypofractionated high dose rate boost and external beam radiotherapy","volume":"79","author":"Martinez","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.10.007_b0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0360-3016(00)00436-3","article-title":"Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavourable prostate cancer: the William Beaumont phase II dose escalating trial","volume":"47","author":"Martinez","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.10.007_b0025","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ijrobp.2009.01.059","article-title":"Phase II trial of radiation dose escalation with conformal external beam radiotherapy and high dose rate brachytherapy combined with long term androgen suppression in unfavourable prostate cancer: feasibility report","volume":"76","author":"Valero","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.10.007_b0030","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/sj.bjc.6602301","article-title":"Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects","volume":"92","author":"Dearnaley","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2014.10.007_b0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2007.04.011","article-title":"High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial","volume":"84","author":"Hoskin","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2014.10.007_b0040","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ijrobp.2007.11.066","article-title":"Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes","volume":"71","author":"Zelefsky","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.10.007_b0045","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.294.10.1233","article-title":"Comparison of conventional-dose vs. high dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial","volume":"294","author":"Zietman","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.radonc.2014.10.007_b0050","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0360-3016(98)00438-6","article-title":"Fractionation and protraction for radiotherapy of prostate carcinoma","volume":"43","author":"Brenner","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.10.007_b0055","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/02841860410002824","article-title":"The radiobiology of prostate cancer including new aspects of fractionated radiotherapy","volume":"44","author":"Fowler","year":"2005","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2014.10.007_b0060","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0360-3016(02)03828-2","article-title":"How low is the \u03b1\/\u03b2 ratio for prostate cancer?","volume":"55","author":"Wang","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.10.007_b0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijrobp.2012.03.004","article-title":"Meta-analysis of the alpha\/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news?","volume":"85","author":"Vogelius","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.10.007_b0070","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.clon.2013.04.009","article-title":"Brachytherapy: current status and future strategies \u2013 can high dose rate replace low dose rate and external beam radiotherapy?","volume":"25","author":"Morton","year":"2013","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2014.10.007_b0075","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/01.ju.0000113299.34404.22","article-title":"High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds","volume":"171","author":"Grills","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2014.10.007_b0080","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/j.ijrobp.2010.07.365","article-title":"Interstitial high dose rate (HDR) brachytherapy as monotherapy for early stage prostate cancer: median 8year results in 312 patients","volume":"78","author":"Mark","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.10.007_b0085","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijrobp.2010.10.009","article-title":"Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer","volume":"82","author":"Mohammed","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.10.007_b0090","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.radonc.2008.11.013","article-title":"Urethral stricture following high dose rate brachytherapy for prostate cancer","volume":"91","author":"Sullivan","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2014.10.007_b0095","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.ijrobp.2011.04.031","article-title":"High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence","volume":"82","author":"Hoskin","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.10.007_b0100","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijrobp.2007.12.026","article-title":"A Phase II study of high-dose-rate after loading brachytherapy as monotherapy for the treatment of localized prostate cancer","volume":"72","author":"Corner","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.10.007_b0105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.radonc.2009.09.015","article-title":"Justification for inter-fraction correction of catheter movement in fractionated high dose-rate brachytherapy treatment of prostate cancer","volume":"93","author":"Simnor","year":"2009","journal-title":"Radiother Oncol"},{"year":"1975","series-title":"Nonparametrics: statistical methods based on ranks","key":"10.1016\/j.radonc.2014.10.007_b0110"},{"year":"1969","series-title":"The chi-squared distribution","key":"10.1016\/j.radonc.2014.10.007_b0115"},{"key":"10.1016\/j.radonc.2014.10.007_b0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0360-3016(01)01811-9","article-title":"The dosimetry of prostate brachytherapy-induced urethral strictures","volume":"52","author":"Merrick","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.10.007_b0125","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0022-5347(05)00681-6","article-title":"Risk factors for the development of prostate brachytherapy related urethral strictures","volume":"175","author":"Merrick","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2014.10.007_b0130","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijrobp.2004.12.068","article-title":"Detailed urethral dosimetry in evaluation of prostate brachytherapy-related urinary morbidity","volume":"62","author":"Allen","year":"2005","journal-title":"Int J Radiol Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.10.007_b0135","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ijrobp.2008.12.051","article-title":"Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer","volume":"75","author":"Konishi","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.10.007_b0140","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0360-3016(99)00477-0","article-title":"Needle displacement during HDR-brachytherapy in treatment of prostate cancer","volume":"46","author":"Damore","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.10.007_b0145","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2007.11.004","article-title":"HDR prostate monotherapy: dosimetric effects of implant deformation due to posture change between TRUS- and CT-imaging","volume":"86","author":"Seppenwoolde","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2014.10.007_b0150","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ijrobp.2010.03.030","article-title":"Clinical Trials of a urethral dose measurement system in brachytherapy using scintillation detectors","volume":"79","author":"Suchowerska","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2014.10.007_b0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijrobp.2008.11.006","volume":"75","author":"Ishiyama","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814014004150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814014004150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T21:44:52Z","timestamp":1566078292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814014004150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0167814014004150"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2014.10.007","relation":{},"ISSN":["0167-8140"],"issn-type":[{"type":"print","value":"0167-8140"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosimetric analysis of urethral strictures following HDR 192Ir brachytherapy as monotherapy for intermediate- and high-risk prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2014.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}